menu
    • menu

    Company profile for Agios Pharmaceuticals

    NEW Drugs in Dev: 12
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Agios, our culture and values – which form the foundation of our company and differentiate us – are embodied in the Greek word Arete, the ancient ideal of excellence and fulfillment of one’s potential. Arete has several meanings, and each is applicable to our company. It is often used to describe virtue, to characterize someone as a “good person.” Our company comprises good people who are striving to achieve a vir...
    At Agios, our culture and values – which form the foundation of our company and differentiate us – are embodied in the Greek word Arete, the ancient ideal of excellence and fulfillment of one’s potential. Arete has several meanings, and each is applicable to our company. It is often used to describe virtue, to characterize someone as a “good person.” Our company comprises good people who are striving to achieve a virtuous goal. It also connotes a sense of driving for excellence, which speaks to how far we can push ourselves and reflects our focus on achieving “the other side of possible.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Agios PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    88 Sidney Street Cambridge, MA 02139-4169
    Telephone
    Telephone
    617-649-8600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.agios.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/agios/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/agiospharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    India Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    India Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Agios To Host Q1 2026 Financial Results Conference On April 29
    Agios To Host Q1 2026 Financial Results Conference On April 29

    06 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/06/3268336/31990/en/Agios-to-Host-First-Quarter-2026-Financial-Results-Conference-Call-and-Webcast-on-April-29-at-8-00-a-m-ET.html

    GLOBENEWSWIRE
    06 Apr 2026
    Share Share
    Agios Advances Mitapivat Toward SCD Accelerated Approval
    Agios Advances Mitapivat Toward SCD Accelerated Approval

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3265325/31990/en/Agios-Advances-Mitapivat-Toward-Potential-U-S-Accelerated-Approval-in-Sickle-Cell-Disease-Following-Pre-sNDA-Meeting-with-FDA.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share
    Agios Reports Q4 2025 Financial Results And Business Update
    Agios Reports Q4 2025 Financial Results And Business Update

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3237003/31990/en/Agios-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share
    Agios To Host Q4 2025 Financial Results Conference On Feb 12
    Agios To Host Q4 2025 Financial Results Conference On Feb 12

    26 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/26/3225475/31990/en/Agios-to-Host-Fourth-Quarter-and-Full-Year-2025-Financial-Results-Conference-Call-and-Webcast-on-February-12-at-8-00-a-m-ET.html

    GLOBENEWSWIRE
    26 Jan 2026
    Share Share
    Agios Details 2026 Strategy To Boost Rare Disease Portfolio
    Agios Details 2026 Strategy To Boost Rare Disease Portfolio

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216709/31990/en/Agios-Outlines-2026-Strategic-Priorities-and-Key-Milestones-to-Accelerate-Rare-Disease-Portfolio-Growth.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Agios To Present At J.P. Morgan Healthcare Conference
    Agios To Present At J.P. Morgan Healthcare Conference

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212595/31990/en/Agios-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference-on-January-14-2026.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search